SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Myriad Genetics, Inc. (MYGN)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
2355 65 0 MYGN
Emcee:  s myers Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1455Interesting piece on AD. Not sure if this is the best place to post this. By LLJM-6/20/2005
1454<i>The presentation, by Professor Gordon Wilcock, M.D., the trial's prscaram(o)uche-6/20/2005
1453the frustrating thing..... this anchor around our neck..... it was predictabscaram(o)uche-6/20/2005
1452>><i>Is there any precedent for their strategy working?>></LJM-6/20/2005
1451Having worked in the leveraged finance/LBO space for many years, this one actualRobohogs-6/20/2005
1450Sounds fine to me. Meldrum is making a fundamental error. He's either lettscaram(o)uche-6/20/2005
1449How about an LBO by Warburg? PM alone could be sold off to get back cost. JonRobohogs-6/20/2005
1448>> Is there any precedent for their strategy working? << Not that Iscaram(o)uche-6/20/2005
1447I just sent off an email to MYGN echoing the concerns expressed here. Is therTomato-6/20/2005
1446I was disappointed that MYGN still insists going it alone with Flurizan trials. LJM-6/20/2005
1445mygn coming up on CNBC after current commercial break, tickler was PM-related.scaram(o)uche-6/20/2005
1444finance.messages.yahoo.com >> gets shot in the kneecaps!!! << Therscaram(o)uche-6/20/2005
1443Myriad Genetics Presents Results Of Phase 2 Trial Of Flurizan™ In Patients With Lee39-6/20/2005
1442"Promise In Alzheimer's Fight (06-20) 06:01 PDT WASHINGTON, (AP) -- Lee39-6/20/2005
1441meldrum: In 1996, your salary and bonus for were $175K and $90K, respectively. scaram(o)uche-6/20/2005
1440So write the company? So go to Yahoo and embarrass Meldrum together with me, inscaram(o)uche-6/20/2005
1439<i>committing the company to going it alone with a larger trial...</i&gnigel bates-6/20/2005
1438METHOD AND COMPOSITION FOR TREATING NEURODEGENERATIVE DISORDERS Patent number: scaram(o)uche-6/20/2005
1437<i>Based on the Phase 2 results and consultation with Alzheimer's disescaram(o)uche-6/20/2005
1436Myriad Genetics Presents Results of Phase 2 Trial of Flurizan(TM) in Patients Wiscaram(o)uche-6/20/2005
1435results out. not in yahoo's feed yet, don't know why. adverse events fscaram(o)uche-6/20/2005
1434Geneticists oppose singling out Jewish women in European breast cancer patent Jsim1-6/19/2005
1433Given MYGN PM business is in cancer, building a cancer specialty center of excelLee39-6/18/2005
1432<pre>COMPENSATION OF NAMED EXECUTIVE OFFICERS Name and Position -------scaram(o)uche-6/18/2005
1431meldrum: In 1996, your salary and bonus for were $175K and $90K, respectively. scaram(o)uche-6/18/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News